| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.15▲ | 9.15▲ | 9.10▲ | 9.04▲ | 9.06▲ |
| MA10 | 9.08▲ | 9.08▲ | 9.06▲ | 9.04▲ | 9.10▲ |
| MA20 | 9.07▲ | 9.06▲ | 9.06▲ | 8.99▲ | 8.87▲ |
| MA50 | 9.04▲ | 9.05▲ | 9.04▲ | 9.03▲ | 8.91▲ |
| MA100 | 9.05▲ | 9.11▲ | 9.11▲ | 8.79▲ | 10.29▼ |
| MA200 | 9.15▲ | 9.07▲ | 9.08▲ | 8.59▲ | 17.92▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.018▲ | 0.018▲ | 0.015▲ | 0.017▲ | 0.041▲ |
| RSI | 57.611▲ | 56.232▲ | 56.639▲ | 58.191▲ | 54.840▲ |
| STOCH | 69.974 | 69.974 | 53.307 | 15.203▼ | 44.116 |
| WILL %R | -9.259▲ | -38.750 | -38.750 | -65.541 | -44.969 |
| CCI | 110.791▲ | 74.660 | 92.229 | 152.372▲ | 17.831 |
| ▲ MACD | $XLO MACD(12,26,9) Crossed Above Zero | Set Alert |
|
Monday, September 28, 2026 12:29 AM
WALTHAM, Mass., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 29/09/26 | 9.21 | 9.21 | 9.185 | 9.185 | 2,689 |
| 28/09/26 | 9.21 | 9.22 | 8.96 | 9.05 | 11,128 |
| 25/09/26 | 9.00 | 9.21 | 8.93 | 9.04 | 3,418 |
| 24/09/26 | 8.93 | 9.09 | 8.93 | 9.00 | 16,005 |
| 23/09/26 | 9.03 | 9.04 | 8.94 | 8.94 | 1,275 |
| 22/09/26 | 9.04 | 9.16 | 8.9501 | 9.04 | 6,877 |
| 21/09/26 | 8.96 | 9.175 | 8.96 | 9.02 | 7,132 |
| 18/09/26 | 8.995 | 9.67 | 8.94 | 9.13 | 22,936 |
| 17/09/26 | 9.00 | 9.0491 | 8.93 | 9.04 | 14,427 |
| 16/09/26 | 9.02 | 9.02 | 8.93 | 8.98 | 11,532 |
|
|
||||
|
|
||||
|
|